Please login to the form below

Not currently logged in

Icelandic genome study yields new disease genes

Alzheimer's disease brain scan

Nature Medicine study focuses on the probability of developing Alzheimer’s

Takeda's once-weekly DPP-4 inhibitor cleared in first market

Takeda pharma buildingZafatek’s authorisation one of a flurry new approvals for a number of firms in Japan

WHO: Medicine costs ‘too high’ for European governments

Dr Margaret Chan - director general, WHONew report shows transparency and co-operation needed to help reduce drug prices

Final NICE ‘no’ for Celgene’s Imnovid

England’s pricing watchdog says multiple myeloma drug is just too expensive for the NHS

AZ links with Harvard for diabetes research

AstraZeneca AZ headquarters London UKFirm extends ties with the highly respected academic institution in hope of finding innovative leads

Merck's Keytruda beats BMS' Yervoy in melanoma face-off

merck-keytruda-pembrolizumab-melanomaBoth firms competing for a leading share in the highly competitive skin cancer drug market

Novo Nordisk sheds autoimmune portfolio to BMS

Novo Nordisk headquartersContinues the trend of pharma buying up unwanted assets from rival firms

Cancer charity partners with research council for innovation

pharmacy standardCRUK teams up with multi-disciplinary groups to help develop new oncology products

Dendreon wins IQWiG U-turn for its immunotherapy Provenge

German HTA body IQWiGNew data for its troubled cancer drug convinces German HTA body of its added benefit

The end of hepatitis C?

Next-gen hep C therapies may see the disease's global elimination - but treament access must be stepped up dramatically

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, market access, healthcare digital excellence, and strategic consultancy. We bring...

Latest intelligence

Certainly, not!
Conventional wisdom acknowledges the inevitability of uncertainty. And Socrates apparently said something about it too, so it must be right (“As for me, all I know is that I know...
Curbing the rise of drug resistance
The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance...
Understanding the ‘adoption ladder’ in closed loop marketing
Did you know that the very barriers to your product can be turned around to drive its success? Learn the judo strategy that is at the heart of great e-detailing....